Novel therapies to enhance anti-tumour immunity

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1139626

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Immunotherapy is a new approach to treat cancer, and works by promoting the immune system to attack cancer. Immunotherapies, such as checkpoint blockade and adoptive T cell therapy, are proving to be very successful in certain human cancers. However, combining immunotherapy with drugs that cause cancer cell death may be more effective. This project will investigate the potential of combining immunotherapy with a novel anti-cancer drug, in order to develop more effective treatments for cancer.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $797,601.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Tumour Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer immunology | cancer treatment | cell death | immunotherapy | lymphocytes

Related Links